ArticleWorld journal of hepatology2022

Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma.

Ghada Abdelrahman Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.